v3.26.3
Financial Instruments
9 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Investments, All Other Investments [Abstract]    
Financial Instruments

Note 14 - Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value hierarchy ranks the inputs used in measuring fair value as follows:

 

  ○ Level 1 – Observable, unadjusted quoted prices in active markets
  ○ Level 2 – Inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability
  ○ Level 3 – Unobservable inputs with little or no market activity that require the Company to use reasonable inputs and assumptions

 

The Company uses fair value measurements to record adjustments to certain financial assets and liabilities on a recurring basis. The Company may be required to record certain assets at fair value on a nonrecurring basis in specific circumstances, such as evidence of impairment. Methodologies used to determine fair value might be highly subjective and judgmental in nature; therefore, valuations may not be precise. If the Company determines that a valuation technique change is necessary, the change is assumed to have occurred at the end of the respective reporting period.

 

Recurring Fair Value Measurements

 

The Company’s financial liabilities measured at fair value on a recurring basis consist of warrant liabilities, valued using Level 1 (quoted market prices) or Level 3 (internally developed option-pricing models) inputs. The Company holds no Level 2 instruments. The following table presents these liabilities by level of the fair value hierarchy as of September 30, 2026 and December 31, 2025:

  

Liability (in thousands)  Total Fair Value   Level 1   Level 3   Total Fair Value   Level 1   Level 3 
   September 30, 2026   December 31, 2025 
Liability  Total Fair Value   Level 1   Level 3   Total Fair Value   Level 1   Level 3 
PIPE warrants  $—   $—   $—   $280   $—   $280 
Public warrants   240    240    —    10,896    10,896    — 
Private placement warrants   —    —    —    14    —    14 
Abaca warrants   58    —    58    28,430    —    28,430 
Total liabilities  $298   $240   $58   $39,620   $10,896   $28,724 

 

Nearly all warrant values declined from December 31, 2025 to September 30, 2026, reflecting a decline in the Company’s share price over the period, as further discussed below.

 

 

Nonrecurring Fair Value Measurements

 

During the nine months ended September 30, 2026, the Company added three new loans to the indemnified CRB portfolio, one of which was added during the three months ended September 30, 2026. As a result, the Company initially recognized new stand-ready guarantee liabilities at an aggregate fair value of $0.01 million for the nine months ended September 30, 2026, of which $0.002 million related to the loan that was added during the three months ended September 30, 2026. These fair values were determined using the Level 3 insurance-pricing methodology described below. No other assets or liabilities were measured at fair value on a nonrecurring basis during the three or nine months ended September 30, 2026.

 

The Company recognized a stand-ready guarantee liability under ASC 460 in connection with the Second Amended CAA with PCCU, initially at inception on October 1, 2025. The liability is measured at fair value once, at inception, and is not subsequently remeasured; it is reduced through systematic amortization as the Company is progressively released from risk on the underlying loan portfolio. As of December 31, 2025, the carrying amount of this liability was $2 million. The Company determined fair value using an insurance-pricing approach, representing the premium a third-party surety or insurer would charge to assume the same obligation.

 Schedule of Non-Recurring Fair Value Measurement

Liability (as of initial recognition, October 1, 2025)  Carrying Amount   Fair Value   Level 3 Input 
Stand-ready guarantee liability  $2,135,000   $2,135,000   $2,135,000 

 

Fair Value of Financial Instruments

 

The following tables present the carrying amounts and fair values of the Company’s financial instruments, by level of the fair value hierarchy, as of September 30, 2026 and December 31, 2025. In each case, carrying value approximates fair value.

 

September 30, 2026  Carrying Amount   Fair Value   Level
Assets             
Cash and cash equivalents  $4,396,069   $4,396,069   Level 1
Liabilities             
Deferred consideration   3,000,000    3,000,000   Level 1
Public warrants   240    240   Level 1
Abaca warrants   58    58   Level 3

 

December 31, 2025  Carrying Amount   Fair Value   Level
Assets             
Cash and cash equivalents  $6,779,040   $6,779,040   Level 1
Investment in preferred securities   1,450,000    1,450,000   Level 3
Liabilities             
Deferred consideration   3,000,000    3,000,000   Level 1
Public warrants   10,896    10,896   Level 1
Private placement warrants   14    14   Level 3
PIPE warrants   280    280   Level 3
Abaca warrants   28,430    28,430   Level 3

 

 

Changes in Level 3 Liabilities

 

The following tables present the changes in the Company’s Level 3 liabilities measured at fair value on a recurring basis for the nine months ended September 30, 2026 and September 30, 2025. All changes during each period were attributable to fair value adjustments, with no purchases, issuances, or settlements:

 

Nine Months Ended September 30, 2026  PIPE Warrants   Abaca Warrants  

Private Placement Warrants

 
Balance, January 1, 2026  $280   $28,430   $14 
Fair value adjustment   (280)   (28,372)   (14)
Balance, September 30, 2026  $-   $58   $- 

 

Nine Months Ended September 30, 2025  PIPE Warrants   Abaca Warrants   Private Placement Warrants   Third Anniversary Payment Consideration   Forward Purchase Derivative 
Balance, January 1, 2025  $79,512   $1,024,900   $9,632   $322,000   $7,309,580 
Fair value adjustment   (40,439)   (313,986)   (5,669)   (63,132)   - 
Exchanged for Series B Convertible Preferred Stock and Series B Warrants   -    -    -    -    (7,309,580)
Balance, September 30, 2025  $39,073   $710,914   $3,963   $258,868   $- 

 

Quantitative Information About Level 3 Fair Value Measurements

 

The PIPE warrants, private placement warrants, and Abaca warrants are valued using the Black-Scholes-Merton option pricing model. The following tables present the significant unobservable inputs used in these valuations as of September 30, 2026 and December 31, 2025:

 

As of September 30, 2026  PIPE Warrants   Private Placement Warrants   Abaca Warrants 
Exercise price  $1,200   $2,760   $480 
Share price  $1.50   $1.50   $1.50 
Expected term (years)   0.99    0.99    2.07 
Volatility   117%   117%   117%
Risk-free rate   4.5%   4.5%   4.5%

 

As of December 31, 2025  PIPE Warrants   Private Placement Warrants   Abaca Warrants 
Exercise price  $1,200   $2,760   $480 
Share price  $12.72  $12.72   $12.72 
Expected term (years)   1.74    1.74    2.82 
Volatility   115%   115%   115%
Risk-free rate   3.5%   3.5%   3.5%

 

 

There were no transfers between Level 2 and Level 3 of the fair value hierarchy during either period presented.

 

Assets and liabilities measured at fair value on a nonrecurring basis

 

The Company’s only asset subject to fair value measurement on a nonrecurring basis is its right-of-use asset associated with its office lease, which is tested for impairment when indicators are present. No impairment indicators were identified during the nine months ended September 30, 2026.

 

The Company also recognizes a stand-ready guarantee liability under ASC 460 in connection with the Second Amended CAA with PCCU. A new stand-ready guarantee liability is initially recognized at fair value each time a new loan is added to the indemnified CRB loan portfolio, using the Level 3 insurance-pricing methodology described above, consistent with the market participant framework of ASC 820-10-35-9. Once recognized, each liability is not subsequently remeasured to fair value; it is instead reduced through systematic amortization as the Company is progressively released from risk on the underlying loan. During the three and nine months ended September 30, 2026, one and two new loans, respectively, were added to the indemnified portfolio, resulting in the recognition of new stand-ready guarantee liabilities with fair values of approximately $0.001 million and $0.01 million, respectively.

 

Level 3 Measurement - Significant Unobservable Inputs

 

The ASC 460 Guarantee liability was classified as Level 3 because its fair value was determined using significant unobservable inputs for which there is no active market. The following table summarizes the valuation methodology and significant unobservable inputs used in the Level 3 measurement for those loans indemnified at October 1, 2025:

  

Input   Value Used   Sensitivity
Probability of Default -Tranches A & B (Ratings 2–5, pooled)   7.25%, derived from loan level analysis of the portfolio.   An increase raises fair value
Probability of Default - Tranche C (Rating 9, individually evaluated)   35%, based on Rating 9 definition, past-maturity status, and personal guarantees   An increase raises fair value
Loss Given Default - Tranches A & B   25.00% for Tranche A and 35% for Tranche B, inclusive of 13% cannabis-specific qualitative premium reflecting court access limitations, collateral possession restrictions, and refinancing risk   An increase raises fair value
Loss Given Default - Tranche C (uncollateralized gap)   50%, representing the midpoint of the Rating 9 anticipated loss range applied to the uncollateralized exposure   An increase raises fair value
Stand-Ready Risk Premium   120% loading applied to total expected loss, reflecting compensation for uncapped exposure, cannabis concentration risk, portfolio illiquidity, and six-year guarantee term commitment   An increase raises fair value
Discount Rate   4.0% risk-free rate (6-year Treasury)   An increase reduces fair value
Weighted Average Payout Timing   Tranche A: 4 years; Tranche B: 3 years; Tranche C: 2 years; Stand-ready premium: 3 years — based on the portfolio’s contractual maturity profile   A longer weighted average payout timing reduces fair value

 

 

For loans entered into subsequent to October 1, 2025 (the inception date), management evaluates the stand-ready guarantee on a specific identification basis, separate from the pooled tranche inputs presented above. Loans originated under this methodology are evaluated using the tranche-specific assumptions determined at each loan’s origination date, as follows:

 

Origination Quarter  # Loans   PD   LGD (incl. cannabis qualitative premium)   Stand-Ready Risk Premium Loading  Discount Rate   Weighted Avg Payout
Three months ended September 30, 2026   1    7.25%   25%  120% of expected loss   5.0%  5 years

 

 

Origination Quarter  # Loans   PD   LGD (incl. cannabis qualitative premium)   Stand-Ready Risk Premium Loading  Discount Rate  Weighted Avg Payout
Nine months ended September 30, 2026   3    7.25%   25%  120% of expected loss  4.4% to 5.0%  5 years

 

Note 17 - Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value hierarchy ranks the inputs used in measuring fair value as follows:

 

  ○ Level 1 - Observable, unadjusted quoted prices in active markets
  ○ Level 2 - Inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability
  ○

Level 3 - Unobservable inputs with little or no market activity that require the Company to use reasonable inputs and assumptions

 

The Company uses fair value measurements to record adjustments to certain financial assets and liabilities on a recurring basis. The Company may be required to record certain assets at fair value on a nonrecurring basis in specific circumstances, such as evidence of impairment. Methodologies used to determine fair value might be highly subjective and judgmental in nature; therefore, valuations may not be precise. If the Company determines that a valuation technique change is necessary, the change is assumed to have occurred at the end of the respective reporting period.

 

Assets and Liabilities Reported at Fair Value on a Recurring Basis

 

Public Warrants:

 

Public warrants are recorded at fair value on a recurring basis. The Company obtains exchange traded price, of Level 1 inputs, based on observable data to value these warrants.

 

Private Placement Warrants:

 

Private Placement Warrants are recorded at fair value on a recurring basis based upon an internal Company assessed value of these derivatives with Level 3 inputs, which are derived from the Black-Scholes model.

 

PIPE Warrants:

 

PIPE Warrants are recorded at fair value on a recurring basis based upon an internal Company assessed value of these derivatives with Level 3 inputs, which are derived from the Black-Scholes model.

 

Abaca Warrants:

 

Abaca Warrants are recorded at fair value on a recurring basis. The Company assessed the value of these derivatives with Level 3 inputs. Level 3 inputs, based on unobservable data derived from the Black-Scholes model.

 

Third anniversary payment consideration:

 

The third anniversary payment consideration was classified as a derivative liability under ASC 815, Derivatives and Hedging, and was recorded at fair value on a recurring basis using Level 3 inputs. On October 3, 2025, the third anniversary payment of $1.5 million, which was due in October 2025, was settled in full through the issuance of 3,127 shares of Common Stock at a floor value of $480.00 per share at the Company’s election. As a result of this settlement, the liability was fully extinguished during the year ended December 31, 2025.

 

Forward purchase option derivatives:

 

Forward purchase option derivatives are recorded at fair value on a recurring basis. On September 30, 2025, all three FPA holders entered into Exchange and Cancellation Agreements with the Company, pursuant to which they irrevocably cancelled, waived, and terminated all of their rights under the FPA in exchange for shares of Series B Convertible Preferred Stock and Series B Warrants to purchase Class A Common Stock. This transaction extinguished the FPA derivative liability in its entirety and was accounted for as a debt extinguishment under ASC 405-20, resulting in a gain on extinguishment of $3.3 million recognized in Other Income (Expense) for the year ended December 31, 2025.

 

 

The following tables summarize financial assets and liabilities recorded at fair value on a recurring basis, by the level of valuation inputs in the fair value hierarchy on December 31, 2025 and December 31, 2024:

 

 Schedule of Financial Assets and Liabilities Recorded at Fair Value

                              
   December 31, 2025   December 31, 2024 
   Total Fair Value  

Quoted Prices in Active Markets

(Level 1)

  

Significant Other Unobservable Inputs

(Level 3)

   Total Fair Value  

Quoted Prices in Active Markets

(Level 1)

  

Significant Other
Unobservable
Inputs

(Level 3)

 
Description                              
Liabilities:                              
PIPE warrants  $280   $-   $280   $79,512  

$

-  

$

79,512 
Public warrants   10,896    10,896    -    246,445    246,445    - 
Private placement warrants   14    -    14    9,632    -    9,632 
Abaca warrant   28,430    -    28,430    1,024,900    -    1,024,900 
Forward purchase derivative liability   -    -    -    7,309,580    -    7,309,580 
Third anniversary payment consideration   -    -    -    322,000    -    322,000 

 

Assets Measured at Fair Value on a Nonrecurring Basis

 

Assets that are measured at fair value on a nonrecurring basis primarily comprises of property, plant and equipment, right-to-use assets, finite lived intangible assets and goodwill. The Company does not record these at fair value on a recurring basis, however, the carrying value of the assets may be reduced to fair value when the Company determines that impairment has occurred.

 

As of December 31, 2024, the Company had no assets or liabilities measured at fair value on a non-recurring basis. During the year ended December 31, 2025, the Company recognized the ASC 460 stand-ready guarantee liability under the Second Amended CAA at fair value on a non-recurring basis upon initial recognition on October 1, 2025. This liability was measured at inception only and is not remeasured at fair value in subsequent reporting periods. The carrying amount as of December 31, 2025 was $2.1 million, reflecting the systematic release of the liability as the Company is progressively released from risk on the underlying loan portfolio. The fair value measurement for stand-ready guarantee liability was prepared internally by management using an insurance-pricing methodology, reflecting the premium that a knowledgeable, willing third-party surety or specialty insurer would charge to assume the indemnification obligation in an arm’s-length transaction, consistent with the market participant framework of ASC 820-10-35-9.

 

The following table summarizes this non-recurring fair value measurement as of the initial recognition date:

 

 Schedule of Non-Recurring Fair Value Measurement

                    
   December 31, 2025 
   Carrying amount
$
   Fair value
$
   Fair value measurement using 
           Level 1
$
   Level 2
$
   Level 3
$
 
Liabilities                    
Stand-ready guarantee liability  $2,135,000   $2,135,000   $-   $-   $2,135,000 

 

Level 3 Measurement - Significant Unobservable Inputs

 

The ASC 460 Guarantee liability was classified as Level 3 because its fair value was determined using significant unobservable inputs for which there is no active market. The following table summarizes the valuation methodology and significant unobservable inputs used in the Level 3 measurement:

 

 Schedule of Valuation Methodology and Significant Unobservable Inputs

Input   Value Used   Sensitivity
Probability of Default -Tranches A & B (Ratings 2-5, pooled)   7.25%, derived from loan level analysis of the portfolio.   An increase raises fair value
Probability of Default - Tranche C (Rating 9, individually evaluated)   35%, based on Rating 9 definition, past-maturity status, and personal guarantees   An increase raises fair value
Loss Given Default - Tranches A & B   25.00% for Tranche A and 35% for Tranche B, inclusive of 13% cannabis-specific qualitative premium reflecting court access limitations, collateral possession restrictions, and refinancing risk   An increase raises fair value
Loss Given Default - Tranche C (uncollateralized gap)   50%, representing the midpoint of the Rating 9 anticipated loss range applied to the uncollateralized exposure   An increase raises fair value
Stand-Ready Risk Premium   120% loading applied to total expected loss, reflecting compensation for uncapped exposure, cannabis concentration risk, portfolio illiquidity, and six-year guarantee term commitment   An increase raises fair value
Discount Rate   4.0% risk-free rate (6-year Treasury)   An increase reduces fair value
Weighted Average Payout Timing   Tranche A: 4 years; Tranche B: 3 years; Tranche C: 2 years; Stand-ready premium: 3 years - based on the portfolio’s contractual maturity profile   A longer weighted average payout timing reduces fair value

 

 

Fair Value of Financial Instruments

 

The following tables present the carrying amounts and fair values of financial instruments on a non-recurring basis, by the level of valuation inputs in the fair value hierarchy, as of December 31, 2025 and December 31, 2024:

 

           Level 1
$
   Level 2
$
   Level 3
$
 
   December 31, 2025 
   Carrying amount
$
   Fair value
$
   Fair value measurement using 
           Level 1
$
   Level 2
$
   Level 3
$
 
Assets                    
Cash and cash equivalents  $6,779,040   $6,779,040   $6,779,040   $-   $- 
Investment in preferred securities   1,450,000    1,450,000    -    -    1,450,000 
Liabilities                         
Deferred consideration   3,000,000    3,000,000    3,000,000    -    - 
Public warrants   10,896    10,896    10,896    -    - 
Private placement warrants   14    14    -    -    14 
PIPE warrants   280    280    -    -    280 
Abaca warrants   28,430    28,430    -    -    28,430 

 

          

Level 1
$

  

Level 2
$

  

Level 3
$

 
   December 31, 2024 
  

Carrying amount
$

  

Fair value
$

   Fair value measurement using 
          

Level 1
$

  

Level 2
$

  

Level 3
$

 
Assets                    
Cash and cash equivalents  $2,324,647   $2,324,647   $2,324,647   $-   $- 
Forward purchase agreement   4,584,221    4,584,221    4,584,221    -    - 
Loans   360,552    359,505    -    -    359,505 
Liabilities                         
Deferred consideration   3,016,343    3,016,343    3,016,343    -    - 
Senior secured promissory note   11,004,173    10,221,652    -    -    10,221,652 
Public warrants   246,445    246,445    246,445    -    - 
Private placement warrants   9,632    9,632    -    -    9,632 
PIPE warrants   79,512    79,512    -    -    79,512 
Abaca warrants   1,024,900    1,024,900    -    -    1,024,900 
Third anniversary payment consideration   322,000    322,000    -    -    322,000 
Forward purchase derivative   7,309,580    7,309,580    -    -    7,309,580 

 

The change in the liability measured at fair value on a recurring basis for which the Company has utilized Level 3 inputs to determine fair value are presented in the following table:

 

   PIPE Warrants   Abaca Warrant   Private Placement Warrants   Third anniversary payment consideration   Forward Purchase Derivative 
   For the Year Ended December 31, 2025     
   PIPE Warrants   Abaca Warrant   Private Placement Warrants   Third anniversary payment consideration   Forward Purchase Derivative 
Balance, January 1, 2025  $79,512   $1,024,900   $9,632   $322,000   $7,309,580 
Fair value adjustment   (79,232)   (996,470)   (9,618)   (63,133)   - 
Exchanged for Common Stock     -       -       -       258,867       -  
Exchanged for Series B Convertible Preferred Stock and Series B Warrants   -    -    -    -    (7,309,580)
Balance, December 31, 2025  $280   $28,430   $14   $-   $- 

 

   PIPE Warrants   Abaca Warrant   Private Placement Warrants   Third anniversary payment consideration   Forward Purchase Derivative 
   For the Year ended December 31, 2024     
   PIPE Warrants   Abaca Warrant   Private Placement Warrants   Third anniversary payment consideration   Forward Purchase Derivative 
Balance, January 1, 2024  $273,124   $3,384,085   $25,070   $810,000   $7,309,580 
Fair value adjustment   (193,612)   (2,359,185)   (15,438)   (488,000)   - 
Balance, December 31, 2024  $79,512    1,024,900   $9,632   $322,000   $7,309,580 

 

 

As of December 31, 2025 and on December 31, 2024, the fair market of the private placement warrants, Abaca warrants and PIPE warrants, were based on Black-Scholes Merton option pricing model. The valuation was performed by the Company as of December 31, 2025, and by a third-party prior for prior periods.

 

During the year ended December 31, 2025 and December 31, 2024, there were no changes in the classification of financial instruments within Level 2 and Level 3 of the fair value hierarchy.

 

The following table provides quantitative information regarding Level 3 fair value measurements inputs as it relates to the private placement warrants, public warrants, third anniversary payment consideration and Abaca warrants as of their measurement dates:

 

   PIPE Warrants   Private Warrants   Third Anniversary Payment Consideration   Abaca Warrants   PIPE Warrants   Private Warrants   Third Anniversary Payment Consideration   Abaca Warrants 
   As on December 31, 2025       As on December 31, 2024     
   PIPE Warrants   Private Warrants   Third Anniversary Payment Consideration   Abaca Warrants   PIPE Warrants   Private Warrants   Third Anniversary Payment Consideration   Abaca Warrants 
Exercise price  $1,200   $2,760.00   $-   $480.00   $1,200.00   $2,760.00   $-   $480.00 
Share price  $12.72   $12.72   $-   $12.72   $108.00   $108.00   $108.00   $108.00 
Expected term (years)   1.7    1.7    -    2.8    2.7    2.7    0.8    3.87 
Volatility   115%   115%   -    115%   103%   103%   103%   103%
Risk-free rate   3.5%   3.5%   -    3.5%   4.3%   4.3%   4.3%   4.3%

 

On October 3, 2025, the Company issued 3,126 shares of Common Stock to the Abaca shareholders as part of the third anniversary consideration payment under the acquisition agreement (see Note 3), valued at $0.3 million.